Salahi shanli (11 resultados)

Condición: New.

Condición: As New. Unread book in perfect condition.

PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

Condición: New.

Condición: New. Print on Demand.

Condición: New. Print on Demand.

Condición: New. Print on Demand.

Paperback. Condición: new. Paperback. BioCapital expands the BioLionaire Scientist series into the strategic layer of biotechnology - where discovery becomes infrastructure, infrastructure becomes platform, and platform becomes capital.This volume examines the evolving relationship between scientific intelligence and venture creation. It moves beyond laboratory discovery to analyze how translational positioning, intellectual property protection, startup architecture, and investor alignment determine whether deep biology becomes investable biotechnology.Rather than presenting entrepreneurship as a motivational concept, this book frames it as a structural discipline. It connects research strategy to capital formation through the "BioLionaire mindset," demonstrating how scientists can think in systems: discovery, protection, validation, infrastructure, branding, and long-term value creation.From cancer R&D infrastructure and IP defense to startup blueprints and the future of deep biology investing, BioCapital provides a serious framework for researchers who aim to build durable biotech platforms rather than isolated publications.Who This Book Is ForThis volume is written for PhD scientists, postdoctoral researchers, clinician-investigators, deep-tech founders, translational teams, and early-stage biotechnology builders who want to understand how research evolves into venture-grade platforms. It is also appropriate for academic innovation offices, biotech incubators, and institutional libraries supporting entrepreneurship in science.Table of ContentsPart I - The Science-to-BusinessChapter 1 - The New Age of Biotech IntelligenceChapter 2 - The Translational LensChapter 3 - The BioLionaire MindsetPart II - Building the Biotech EngineChapter 4 - The Next Infrastructure For Cancer R&DChapter 5 - Protecting the DiscoveryChapter 6 - The Startup BlueprintChapter 7 - From Bench to BrandPart III - Investing in the FutureChapter 8 - Deep Biology StartupsChapter 9 - Scientists Who Built CapitalChapter 10 - BioCapital 2035AppendicesAppendix A - A Two-Page Map from Laboratory Discovery to Investable VentureAppendix B - Investor Lens BoxesAppendix C - Turn Your Research into a Venture in 12 Months (Checklist)Appendix D - Example SBIR Phase I Grant ProposalGlossaryIndexCompanies Discussed in this VolumeEssential Reading This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Condición: New. Print on Demand.

Paperback. Condición: new. Paperback. BioCapital expands the BioLionaire Scientist series into the strategic layer of biotechnology - where discovery becomes infrastructure, infrastructure becomes platform, and platform becomes capital.This volume examines the evolving relationship between scientific intelligence and venture creation. It moves beyond laboratory discovery to analyze how translational positioning, intellectual property protection, startup architecture, and investor alignment determine whether deep biology becomes investable biotechnology.Rather than presenting entrepreneurship as a motivational concept, this book frames it as a structural discipline. It connects research strategy to capital formation through the "BioLionaire mindset," demonstrating how scientists can think in systems: discovery, protection, validation, infrastructure, branding, and long-term value creation.From cancer R&D infrastructure and IP defense to startup blueprints and the future of deep biology investing, BioCapital provides a serious framework for researchers who aim to build durable biotech platforms rather than isolated publications.Who This Book Is ForThis volume is written for PhD scientists, postdoctoral researchers, clinician-investigators, deep-tech founders, translational teams, and early-stage biotechnology builders who want to understand how research evolves into venture-grade platforms. It is also appropriate for academic innovation offices, biotech incubators, and institutional libraries supporting entrepreneurship in science.Table of ContentsPart I - The Science-to-BusinessChapter 1 - The New Age of Biotech IntelligenceChapter 2 - The Translational LensChapter 3 - The BioLionaire MindsetPart II - Building the Biotech EngineChapter 4 - The Next Infrastructure For Cancer R&DChapter 5 - Protecting the DiscoveryChapter 6 - The Startup BlueprintChapter 7 - From Bench to BrandPart III - Investing in the FutureChapter 8 - Deep Biology StartupsChapter 9 - Scientists Who Built CapitalChapter 10 - BioCapital 2035AppendicesAppendix A - A Two-Page Map from Laboratory Discovery to Investable VentureAppendix B - Investor Lens BoxesAppendix C - Turn Your Research into a Venture in 12 Months (Checklist)Appendix D - Example SBIR Phase I Grant ProposalGlossaryIndexCompanies Discussed in this VolumeEssential Reading This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…